Congress poised for decisive vote on the Chloe Cole Act targeting gender-transition treatments
Representative Bob Onder introduced H.R. 7651, the Chloe Cole Act, which would let families sue providers of puberty blockers, hormones or surgeries performed on minors.
U.S. Rep. Bob Onder (R-MO) has filed H.R. 7651, the Chloe Cole Act, aiming to allow minors' families to bring civil suits against doctors who prescribe puberty blockers, cross-sex hormones or perform sex-reassigning surgeries. The legislation is named for Chloe Cole, a former patient who alleges she was steered into irreversible treatment without full consent. The proposal arrives amid heightened scrutiny of gender-medicine standards, including an FTC complaint against the World Professional Association for Transgender Health and recent malpractice verdicts.
Republican advocates, including Heritage Action, frame the bill as a straightforward affirmation of biological reality and a safeguard for children. Democrats have opposed related measures that would define sex for Title IX and military service. The upcoming vote is presented as a clear choice between common-sense regulation and preserving the existing gender-transition industry.
Why it matters
The bill could reshape how minors receive gender-transition care and expose providers to new lawsuits.
In this story
